| Literature DB >> 12521552 |
Abstract
Fetal cells in maternal blood represent the future of prenatal screening and diagnosis. The possibility of analyzing fetal cells recovered from maternal blood could provide screening and diagnostic protocols characterized by high sensitivity and specificity with no direct risk to the developing fetus. Years of investigation have thus far not led to the development of reliable and consistent protocols; nonetheless, fetal cell recovery promises to be an attractive addition to noninvasive prenatal diagnosis.Mesh:
Year: 2003 PMID: 12521552
Source DB: PubMed Journal: Curr Womens Health Rep ISSN: 1534-5874